Corindus Partners with Houston Methodist DeBakey Heart & Vascular Center to Launch Premier Robotic Training Site for Physicians

Published on:

WALTHAM, MA — December 1, 2017 — Corindus Vascular Robotics, Inc. [NYSE American: CVRS], a leading developer of precision vascular robotics, announced today that Houston Methodist DeBakey Heart & Vascular Center, a leading cardiovascular center located in the Texas Medical Center, has launched the first vascular robotic program in the Houston area with the installation of two CorPath® GRX Systems. In addition and as part of the program launch, Corindus will partner with Houston Methodist to develop a Global Center of Excellence that will seek to advance clinical research on robotics and to train interventional cardiologists on robotic-assisted percutaneous coronary interventions (PCI).

Recently named the No. 1 hospital in Texas for the sixth year in a row by U.S. News & World Report, Houston Methodist Hospital brings together cardiologists, cardiovascular surgeons and cardiovascular anesthesiologists who take a collaborative approach to patient care and research. The hospital, which performs 1,100 PCIs annually, is adopting robotics to improve precision and enhance safety for cath lab professionals.

Mark Toland, President and Chief Executive Officer of Corindus, stated, "Houston Methodist is a world-class center and the ideal partner to educate the interventional community on current applications of robotics. The hospital’s leadership and innovation in cardiovascular medicine will help us to advance the field of vascular robotics."

The Houston Methodist Institute for Technology, Innovation & Education (MITIESM), an innovative virtual hospital and hands-on clinical training facility, will be a robotic-assisted PCI training center. Physicians attending courses at Houston Methodist will participate in didactic education, live case observation with a trained robotic interventionalist, and a unique workshop for a hands-on introduction to robotic-assisted PCI.

Alan Lumsden, M.D., Chief of the Department of Cardiovascular Surgery at Houston Methodist, stated, "We pride ourselves on leading the way in embracing innovative technologies that improve patient care. With adoption of robotics in the cath lab on the rise, comprehensive training programs and innovative product developments are key factors for success."

Related Content

Cardiologists reflect on developing primary PCI in face of criticism and pushback
How TAVR valve choice impacts outcomes when treating type 1 bicuspid AS
IVUS-guided PCI reduces risks in patients with diabetes
Medtronic using AI to identify more TAVR patients in need
SAVR linked to higher 10-year survival rate than TAVR for low-risk patients
LAAC with Watchman FLX reduces bleeding risks after AFib ablation

Around the web

Health Imaging
Use of AI opportunistic screening in CT for cardiovascular disease

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.

Health Imaging
New imaging protocols proposed to curb rise of cardiovascular infections

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.

Radiology Business
What does radiology have to do with climate change?

Kate Hanneman, MD, explains why many vendors and hospitals want to lower radiology's impact on the environment. "Taking steps to reduce the carbon footprint in healthcare isn’t just an opportunity," she said. "It’s also a responsibility."